Precision genetic editing may be the most significant development in molecular biology in the past 50 years. It offers promising new therapies for otherwise incurable diseases, and ways of shaping the world around us for the betterment not just of humanity but of the environment too. But CRISPR-Cas9,the technique at the heart of this breakthrough, has developed some unforeseen complications, putting it into a boat of unintended gene-related consequences shared last week by no less an unlikely fellow creek-paddler than the family entertainment mega giant, Disney. Disney is dealing with its own genetic headache right now, thanks to its merger with Rupert Murdoch’s 21st Century Fox. In the $71-billion deal, Disney does not get Fox News, the so-right-it’s-wrong network news channel so beloved of the US president. This article is only available to Mail & Guardian subscribers at present. Please login or consider subscribing. Visit our FAQs page for more information. Alternatively, check back in a few days when the article becomes freely available. Why can’t I read this article?This article is considered premium content, which is available to subscribers only during the week of publication under the Mail & Guardian’s content embargo system. It’s our way of showing M&G subscribers that we appreciate their support. How does the content embargo system work?
As a reader, you’re able to view content according to the category you fall into: How much does a subscription cost?
Go to M&G subscriptions for our various print and digital subscription offers. How do I share embargoed content on social media?
Premium embargoed content becomes freely available on the Monday after the week of publication, but the link does not change so you can share it immediately or check back on Monday and share it then by clicking on the relevant social media button/s below the story.